FindTrial
Sign In

Vitamin D supplementation reduces serum uric acid concentration in patients with prediabetes and hyperuricaemia

Study to develop clinical and genetically-related methods to use vitamin D and calcium for the prevention of osteoporosis and related disease in Thais

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
TCTR
Registry ID
TCTR20200219002
Enrollment
Unknown
Registered
2020-02-19
Start date
2012-08-30
Completion date
Unknown
Last updated
2026-03-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

&#45

Interventions

no vitamin D supplementation ,vitamin D supplementation
No Intervention Dietary Supplement,Experimental Dietary Supplement
Controls,vitamin D

Sponsors

The National Science and Technology Development Agency of Thailand
Lead Sponsor

Eligibility

Sex/Gender
All
Age
35 Years to 80 Years

Inclusion criteria

Inclusion criteria: - Healthy volunteers aged 35–80 - Were screened for type 2 diabetes by 75 gm OGTT and were diagnosed as impaired fasting glucose and/or impaired glucose tolerance

Exclusion criteria

Exclusion criteria: - Unwilling to participate in the study - Were diagnosed as diabetes or had normal OGTT

Design outcomes

Primary

MeasureTime frame
uric acid baseline and 12 week the uricase method—

Secondary

MeasureTime frame
change in uric acid baseline and 12 week the uricase method—

Countries

Thailand

Contacts

Public ContactHataikarn Nimitphong

Faculty of Medicine Ramathibodi Hospital, Mahidol University

hataikarnn@hotmail.com+6622011647

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Apr 4, 2026